Beam Therapeutics Inc (BEAM) returns
Beam Therapeutics returns over 5 years
$1,000 invested in Beam Therapeutics five years ago was worth $306.75 at the close on October 30, 2026, with dividends reinvested: an average return of -21.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +11.4% | — | $1,114 | -0.9% |
| 3 months | +2.8% | — | $1,028 | +2.1% |
| Year to date | -1.8% | — | $982.32 | +11.7% |
| 1 year | +14.4% | — | $1,144 | +12.4% |
| 3 years | +42.5% | +12.5% | $1,425 | +88.5% |
| 5 years | -69.3% | -21.0% | $306.75 | +76.0% |
Beam Therapeutics return by calendar year
| Year | BEAM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -1.8% | +11.7% | -13.5% |
| 2025 | +11.8% | +17.7% | -5.9% |
| 2024 | -8.9% | +24.9% | -33.8% |
| 2023 | -30.4% | +26.2% | -56.6% |
| 2022 | -50.9% | -18.2% | -32.8% |
| 2021 | -2.4% | +28.7% | -31.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BEAM financials
No forecast, no recommendation. This page describes Beam Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.